Regulation of miRNA-155-5p ameliorates NETosis in pulmonary fibrosis rat model via inhibiting its target cytokines IL-1β, TNF-α and TGF-β1
International Immunopharmacology · 2024
DOI: 10.1016/j.intimp.2023.111456 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Rana Mostafa Adel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Zoology Department, Faculty of Women for Arts, Science and Education, Ain Shams University, 11757, Cairo, Egypt. Electronic address: rana.mostafa@wom…. Hauptthemen laut MEDLINE: Idiopathic Pulmonary Fibrosis, MicroRNAs. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 95 Literaturangaben.
Abstract (Originalsprache)
Idiopathic pulmonary fibrosis (IPF) is an age-related inflammatory disease with no cure up till now.It is accompanied by neutrophils infiltration as the main responders to inflammation and fibrosis. Importantly, neutrophils release neutrophil extracellular traps (NETs) through NETosis process. The function of microRNAs during inflammation became of great biological attention. Owing to microRNAs' central role in immune system, microRNA-155-5p (miR-155-5p) is intensely involved in the inflammatory response. Capsaicin (Cap) is a bioactive compound that exhibits antioxidative and anti-inflammatory functions. Recent studies have shown its role in regulation of certain microRNAs' expressions. Accordingly, the present study aims to investigate the effect of miR-155-5p regulation in suppressing NETs production via ameliorating its target inflammatory cytokines, IL-1ß, TNF-α and TGF-ß1, in bleomycin (BLM)-induced pulmonary fibrosis rat model treated by Cap. The obtained results demonstrated that miR-155-5p downregulation was associated with significant decrease in IL-1ß, TNF-α, TGF-β1, which consequently, reduced hydroxyproline (HYP), NETs activity markers as NE and PAD-4, and alleviated CTGF levels in lung tissues of animals treated by Cap. Furthermore, NETosis ultrastructure examination by transmission electron microscope (TEM), MPO immunohistochemical staining and histopathological studies confirmed an abolishment in NETs formation and an improvement in lung tissue architecture in Cap-treated rats. This study concluded that Cap quenched the inflammatory response through interrupting IL-1β, TNF-α and TGF-β1 pathway via modulating miR-155-5p expression. In addition, Cap was able to alleviate pulmonary NETosis markers by restraining NETs activity markers. These findings provide novel insight into the application of Cap-based treatment in ameliorating pulmonary damage in IPF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zoology Department, Faculty of Women for Arts, Science and Education, Ain Shams University, 11757, Cairo, Egypt. Electronic address: rana.mostafa@women.asu.edu.eg.
- Zoology Department, Faculty of Science, Al-Azhar University, 11884, Nasr City, Cairo, Egypt. Electronic address: Helal@azhar.edu.eg.
- Zoology Department, Faculty of Women for Arts, Science and Education, Ain Shams University, 11757, Cairo, Egypt. Electronic address: dr.mona.ahmed@women.asu.edu.eg.
- Zoology Department, Faculty of Women for Arts, Science and Education, Ain Shams University, 11757, Cairo, Egypt. Electronic address: dr.sahar.sobhy@women.asu.edu.eg.
Zitieren
APA
Adel, R. M., Helal, H., Ahmed Fouad, M., & Sobhy Abd-Elhalem, S. (2024). Regulation of miRNA-155-5p ameliorates NETosis in pulmonary fibrosis rat model via inhibiting its target cytokines IL-1β, TNF-α and TGF-β1. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.111456
Vancouver
Adel RM, Helal H, Ahmed Fouad M, Sobhy Abd-Elhalem S. Regulation of miRNA-155-5p ameliorates NETosis in pulmonary fibrosis rat model via inhibiting its target cytokines IL-1β, TNF-α and TGF-β1. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2023.111456
BibTeX
@article{Adel2024,
author = {Adel, Rana Mostafa and Helal, Hamed and Ahmed Fouad, Mona and Sobhy Abd-Elhalem, Sahar},
title = {Regulation of miRNA-155-5p ameliorates NETosis in pulmonary fibrosis rat model via inhibiting its target cytokines IL-1β, TNF-α and TGF-β1},
journal = {International Immunopharmacology},
year = {2024},
doi = {10.1016/j.intimp.2023.111456}
}
EUVIMED